Antibodies to oncostatin M receptor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 11, 2009
Grant Date -
Aug 3, 2006
app pub date -
Feb 3, 2006
filing date -
Feb 3, 2005
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention provides characterization of the disease and cancer-associated antigen, OSM-R.beta. The invention also provides modulators of OSM-R.beta, including a family of monoclonal antibodies that bind to antigen OSM-R.beta, and methods of diagnosing and treating various human cancers and diseases associated with OSM-R.beta.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully